St Johns Innovation Centre
Astrazeneca advertisement
Advertisement: Barclays Corporate
Advertisement: TTP
Advertisement: Cambridge Network mid banner
Advertisement: PwC midbanner
Advertisement: CJBS mid banner
Advertisement: Mills and Reeve mid banner
31 January, 2011 - 13:37 By Staff Reporter

2005 - Cambridge Antibody Technology


A developer of human monoclonal antibody therapeutics, CAT was the first UK biotech to jointly develop a 'blockbuster' drug. The company was acquired by AstraZeneca in 2006 for £702m and subsequently incorporated into MedImmune, which continues to grow in Cambridge.

CAT was founded in 1989 by, among others, Dr David Chiswell, Dr Greg Winter and the Medical Research Council. AstraZeneca has kept its promise to grow the business globlly from Cambridge and has continued to expand at Granta Park.


Add new comment

Newsletter Subscription

Stay informed of the latest news and features